With a strategic alliance, 24-hour production and a bit of luck, Pfizer and BioNTech were able to roll out their COVID vaccine at a brisk pace and relatively free of controversy.
With a strategic alliance, 24-hour production and a bit of luck, Pfizer and BioNTech were able to roll out their COVID vaccine at a brisk pace and relatively free of controversy.
